Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Insider Q&A: FDA official on vaping's promise or peril

Por: WPLG Local 10 Politics September 26, 2022

thumbnail

WASHINGTON – There’s been no honeymoon period for the Food and Drug Administration’s new tobacco chief, , the public health scientist now responsible for regulating the nation’s multibillion-dollar cigarette and vaping industry.The problems facing FDA’s Center for Tobacco Products have only multiplied since King’s arrival in July from the Centers for Disease Control and Prevention. The FDA missed a summer deadline to review nearly a... + full article



Similar News

ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10


ALS drug wins FDA approval despite questionable data

WPLG Local 10 USA Politics September 30, 2022

thumbnailWASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


Insider Q&A: FDA official on vaping's promise or peril

Associated Press USA Politics September 26, 2022

thumbnailWASHINGTON (AP) — There’s been no honeymoon period for the Food and Drug Administration’s new tobacco chief, , the public health scientist now responsible for regulating the nation’s multibillion-dollar cigarette and vaping industry.The problems facing FDA’s Center for... + más

Insider Q&A: FDA official on vaping's promise or peril | WPLG Local 10

Juul will pay $438.5 million to states over youth vaping investigation | The Verge


FDA concedes delays in response to baby formula shortage

WPLG Local 10 USA Health September 24, 2022

thumbnailWASHINGTON – The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first formal... + más

FDA concedes delays in response to baby formula shortage | ABC News

‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist. | MarketWatch


Juul will pay $438.5 million to states over youth vaping investigation

The Verge USA Health September 24, 2022

thumbnailJuul will pay $438.5 million to states over youth vaping investigationJuul will pay $438.5 million to states over youth vaping investigation / Juul says it’s ‘focused on the future’p>span:first-child]:text-black text-blurple>By Sep 6, 2022, 8:24 PM UTC Share this story... + más

Maine to walk away from multimillion dollar Juul settlement | Portland Press Herald

How McKinsey Got Into the Business of Addiction | The New York Times


FDA concedes delays in response to baby formula shortage

ABC News USA Health September 21, 2022

thumbnailWASHINGTON -- The Food and Drug Administration acknowledged Tuesday that its response to the U.S. infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency... + más

FDA concedes delays in response to baby formula shortage | Associated Press

Internal FDA report on infant formula crisis details shortfalls in response | ABC News


FDA concedes delays in response to baby formula shortage

Associated Press USA Politics September 21, 2022

thumbnailWASHINGTON (AP) — The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first... + más

FDA concedes delays in response to baby formula shortage | ABC News

Internal FDA report on infant formula crisis details shortfalls in response | ABC News



About iurex | Privacy Policy | Disclaimer |